Morning Overview on MSN

The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans

Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get. The FDA approved gadoquatrane, a new gadolinium-based contrast agent designed ...
Medical Xpress

MRI contrast agent design continues path to safer, more effective diagnostics

Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to create a significant advancement in medical imaging technology. Metallo ...